Learn more

JAPANESE FOUND FOR CANCER RES

Overview
  • Total Patents
    15
  • GoodIP Patent Rank
    126,368
  • Filing trend
    ⇩ 100.0%
About

JAPANESE FOUND FOR CANCER RES has a total of 15 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2012. It filed its patents most often in WIPO (World Intellectual Property Organization), Japan and China. Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are CLARKE MICHAEL F, INST PATHOGEN BIOLOGY CAMS and UNI AUT NOMA DE BARCELONA.

Patent filings in countries

World map showing JAPANESE FOUND FOR CANCER RESs patent filings in countries

Patent filings per year

Chart showing JAPANESE FOUND FOR CANCER RESs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Takeuchi Kengo 3
#2 Sakata Seiji 3
#3 Fujita Naoya 3
#4 Katayama Ryohei 3
#5 Seto Mitsutoshi 2
#6 Ogawa Kiyoshi 2
#7 Kajiwara Shigeki 2
#8 Wakui Masatoshi 2
#9 Matsuura Masaaki 2
#10 Nemoto Yuriko 2

Latest patents

Publication Filing date Title
WO2017146253A1 Screening method of anticancer agent focused on function of hp1, and evaluation system
WO2017138500A1 Diagnosis marker for rare hematopoietic tumor, test method, therapeutic agent, and screening method
WO2017122815A1 Novel fusant and method for detecting same
WO2017122816A1 Novel fusion body and method for detecting same
WO2017110764A1 Test method for predicting effectiveness and safety of multi-kinase inhibitor, test kit, and biomarker
WO2017110687A1 Method for identifying cause of lung cancer by mirna, marker, detection kit, and method for screening therapeutic drugs
WO2017061609A1 Tumor determination method
WO2017010463A1 Anti-aggrus monoclonal antibody, domain in aggrus which is required for binding to clec-2, and method for screening for aggrus-clec-2 binding inhibitor
JP2016065869A Tacc3 inhibitor screening method
US2015111888A1 Small compounds targeting TACC3
JP2012237753A Method and device for mass spectrometry data processing